drugset / Trial / NCT00912431
Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers
Non-randomizedCrossoverSingle-blindTreatment
Summary
The objectives of this study are to determine the cerebrospinal fluid (CSF) levels of ABT-126 and to examine the effects of ABT-126 on exploratory biomarkers after administration of a single does of ABT-126 in healthy volunteers.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABT-126 | Small molecule | — | — |
Indications
No indication recorded.